Sign in
4/A

Changes in Ownership

Cellectar Biosciences, Inc. Filed Acc 0001104659-20-029696

Options or other derivatives

  • Chief Financial Officer acquired 10,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Elefant Dov · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-02-03 Grant or award : show line 1 in the form Stock Option (right to buy) +10,000 10,000 D
Loading xslF345X03/tm2011832d2_4a.xml…